Kylo-0603 for fatty liver disease
This trial tests an experimental pill called Kylo-0603 for fatty liver disease (MASLD). The pill may help reduce fat build-up in the liver and improve liver health. It is for people who are overweight or obese with a confirmed fatty liver, but who do not have cirrhosis or other liver conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have fatty liver confirmed by an MRI scan (at least 10% fat).
- Your weight has been steady for the last 6 weeks (no change of more than 5%).
- Your body mass index (BMI) is between 25 and 40.
- You do not have other causes of liver disease (like hepatitis, autoimmune, or alcohol-related).
- You have not used insulin, GLP-1 medicines (like Ozempic), or weight-loss drugs in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.
This trial tests a traditional Chinese herbal capsule called Linzhi Jianghuang Fufang Huoxue Anshen. It aims to see if it can reduce fat in the liver and improve health in people with non-alcoholic fatty liver disease who also have conditions like high blood sugar, blood pressure, or cholesterol.
This trial tests a new medication for people with fatty liver disease. It will see if the drug can reduce liver fat and improve liver health over several doses.
This study tests whether taking a probiotic supplement (a mix of helpful bacteria) can improve liver health in people with fatty liver disease linked to metabolic syndrome. It may help lower liver enzymes and reduce fat buildup in the liver.
This study tests whether a new drug called AZD2389 is safe and well-tolerated in adults with steatotic liver disease (fatty liver) that has progressed to advanced scarring. The trial aims to see if this drug might help slow or improve liver damage in people with this condition.
This trial tests whether a probiotic supplement can improve liver health and metabolism in adults with early signs of fatty liver or related conditions. It may help reduce fat in the liver and improve blood sugar and blood pressure.
Hear when a new Metabolic Dysfunction-Associated Steatoic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.